Literature DB >> 34707222

Anti-TNF dose can be reduced in PsA and axSpA.

Sarah Onuora1.   

Abstract

Entities:  

Year:  2021        PMID： 34707222     DOI： 10.1038/s41584-021-00714-y

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Tumour necrosis factor inhibitor dose adaptation in psoriatic arthritis and axial spondyloarthritis (TAPAS): a retrospective cohort study.

Authors:  Celia A J Michielsens; Nathan den Broeder; Michelle L M Mulder; Frank H J van den Hoogen; Lise M Verhoef; Alfons A den Broeder
Journal:  Rheumatology (Oxford)       Date:  2022-05-30       Impact factor: 7.046
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.